Soliris MOA Animation

With Alexion Pharmaceuticals, we created a Soliris mechanism of action animation for the treatment of Myasthenia Gravis (MG). MG is an autoimmune disorder characterized by neuromuscular transmission failure and subsequent voluntary muscle weakness.

At the start of the project, we were immersed in the existing communication materials for Soliris, including 2D illustrations and concepts. We then built both 3D illustrations and the animation to seamlessly align with those depictions for continuity and clarity. 

Soliris MOA Animation Image 2

Ultimately, the visuals were crafted to explain the mechanism of Soliris and show how damage to the neuromuscular junction could be prevented.

Soliris MOA Animation Image 3

We are so grateful for the collaboration with our clients, and happy to offer our medical animation services for this project!

Related Animations

MPO inhibition in MSA and ALS Animation

MPO inhibition in MSA and ALS Animation